Clinical Trial Update: Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)

View source ↗

Summary

An observational registry of Chinese patients with multiple myeloma treated with lenalidomide (Revlimid) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Status: TERMINATED